Chloramphenicol pharmacokinetics in infants less than three months of age in the Philippines and The Gambia

Pediatric Infectious Disease Journal

Volumn 18, Issue 10, 1999, Pages 896-901

  Weber, Martin W ^a,e   Gatchalian, Salvacion R ^b   Ogunlesi, Olayinka ^a   Smith, Arnold ^c   Mccracken Jr , George H ^d   Qazi, Shamim ^e   Weber, Allan F ^c   Olsen, Kurt ^d   Mulholland, E Kim ^a,e  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Child; Chloramphenicol; Developing countries; Meningitis; Pneumonia

Indexed keywords

CEPHALOSPORIN; CHLORAMPHENICOL;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG METABOLISM; GAMBIA; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; NEWBORN; ORAL DRUG ADMINISTRATION; PHILIPPINES; PRIORITY JOURNAL; TREATMENT INDICATION;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; GAMBIA; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; INJECTIONS, INTRAMUSCULAR; PHILIPPINES;

EID: 0032875914     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199910000-00012     Document Type: Article

References (15)

1. Smith AL, Weber A. Pharmacology of chloramphenicol. Pediatr Clin North Am 1983;30:209-36.
2. Ristuccia AM. Chloramphenicol: clinical pharmacology in pediatrics. Ther Drug Monit 1985;7:159-67.
3. Scott JL, Finegold SM, Belkin GA, Lawrence JS. A controlled double-blind study of the hematological toxicity of chloramphenicol. N Engl J Med 1965;272:1137-42.
4. McCurdy PR. Plasma concentration of chloramphenicol and bone marrow suppression. Blood 1963;21:363-72.
5. Rich ML, Ritterhoff RJ, Hoffman RJ. A fatal case of aplastic anemia following chloramphenicol therapy. Ann Intern Med 1950;33:1459-67.
6. Hellriegel KP, Gross R. Follow-up studies in chloramphenicol-induced aplastic anaemia. Postgrad Med J 1974;50(Suppl 5):136-42.
7. Sutherland JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child 1959;97:761-7.
8. Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med 1960;262:787-94.
9. WHO. Integrated management of childhood illness. Geneva: World Health Organization, Division of Child Health and Development, 1995.
10. Saez-Llorens X, McCracken GH. Perinatal bacterial diseases. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Saunders, 1998:892-926.
11. Shann F, Linnemann V, Mackenzie A, Barker J, Gratten M, Crinis N. Absorption of chloramphenicol sodium succinate after intramuscular administration in children. N Engl J Med 1985;313:410-14.
12. Kauffman RE, Thirumoorthi MC, Buckley JA, Aravind MK, Dajani AS. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children. J Pediatr 1981;99:963-7.
13. Tuomanen EI, Powell KR, Marks MI, et al. Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr 1981;99:968-74.
14. Ismail R, Teh LK, Choo EK. Chloramphenicol in children: dose, plasma levels and clinical effects. Ann Trop Paediatr 1998;18:123-8.
15. Brewster DR, Greenwood BM. Seasonal variation of paediatric diseases in The Gambia, West Africa. Ann Trop Paediatr 1993;13:133-46.